Ibrutinib,Venetoclax
Janssen,Abbvie,Roche
['aml,(-streamline),(-seamless),(-kamloops)', 'cll']
fixed duration ibrutinib and ven provides deep, durable responses and clinically meaningful pfs with an all-oral, once-daily, chemotherapy-free regimen for #cll #asco wonder if we will have fixed therapy approach for older #amlsm patient as well? 
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK